Daily Review: A Second Malaria Vaccine

Daily Review: A Second Malaria Vaccine
A mother holds her baby receiving a malaria vaccine as part of a trial at the Walter Reed Project Research Center in Kombewa, western Kenya, Oct. 30, 2009 (AP photo by Karel Prinsloo).

Today at WPR, we’re covering a significant vulnerability in the Russia-China strategic partnership and China’s global development ambitions.

But first, here’s our take on today’s top story:

Malaria vaccine: The World Health Organization has approved a new anti-malaria vaccine. The R21/Matrix-M, developed by Oxford University, is the second such vaccine to be recommended by the WHO and offers a cheaper and more accessible option to combat the disease. (Washington Post)

Keep reading for free!

Get instant access to the rest of this article by submitting your email address below. You'll also get access to three articles of your choice each month and our free newsletter:

Or, Subscribe now to get full access.

Already a subscriber? Log in here .

What you’ll get with an All-Access subscription to World Politics Review:

A WPR subscription is like no other resource — it’s like having a personal curator and expert analyst of global affairs news. Subscribe now, and you’ll get:

  • Immediate and instant access to the full searchable library of tens of thousands of articles.
  • Daily articles with original analysis, written by leading topic experts, delivered to you every weekday.
  • Regular in-depth articles with deep dives into important issues and countries.
  • The Daily Review email, with our take on the day’s most important news, the latest WPR analysis, what’s on our radar, and more.
  • The Weekly Review email, with quick summaries of the week’s most important coverage, and what’s to come.
  • Completely ad-free reading.

And all of this is available to you when you subscribe today.